Dosing & Dose Management – TAGRISSO® (osimertinib)
Dosing & Administration – gBRCAm, HER2-Negative Metastatic Breast Cancer – LYNPARZA® (olaparib)
Dose Modification Guidelines | NINLARO® (ixazomib)
Dosing & Schedule | ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound)
How to Dose Modify | REVLIMID® (lenalidomide) for MDS
Dose modification for neutropenia or thrombocytopenia at day 8 or 15 | Download Table
IBRANCE® (palbociclib) Recommended Dose Modifications | Safety Info
Dose Modifications | REVLIMID® (lenalidomide) for MCL
KISQALI® (ribociclib) Dosing & Administration | HCP
Examples for modifications of dose adjustments for renal function | Download Table
HALAVEN® (eribulin mesylate) Injection Dose Modification for Advanced Liposarcoma | HCP
LENVIMA® (lenvatinib) HCP Website | Adverse Reaction Management
COTELLIC® (cobimetinib) + ZELBORAF® (vemurafenib) Dose Modification for HCPs
Dose modification scheme for managing palbociclib/placebo-related... | Download Scientific Diagram
Dose Modification for Myelosuppression
Dose modification criteria | Download Table
IBRANCE® (palbociclib) Recommended Dose Modifications | Safety Info
Dose modification of cisplatin in renal impairment | Download Table
Dose Modifications | REVLIMID® (lenalidomide) for MCL
Dose modifications for haematological toxicity | Download Table
ALECENSA® (alectinib) Dose Modifications
Dosing | How to Take CALQUENCE® (acalabrutinib) 100 mg capsules
Dosing for Jakafi in Myelofibrosis | Jakafi HCP
Dosing & Dose Management – TAGRISSO® (osimertinib)
NOVA Dosing | ZEJULA (niraparib)
